Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase
暂无分享,去创建一个
M. D. Chamberlain | R. Chagpar | P. Links | M. Pastor | Levi A Furber | Andrea D Hawrysh | Deborah H Anderson | Andrea D. Hawrysh | Deborah H. Anderson | Levi A. Furber
[1] J. Backer,et al. Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit , 1998, Molecular and Cellular Biology.
[2] T. Mak,et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.
[3] Carlos Cordon-Cardo,et al. Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.
[4] C. Cordon-Cardo,et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] Y. Matsuzawa,et al. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase , 1999, Nature Genetics.
[6] Daniel A. Pollard,et al. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α , 2000, Nature Genetics.
[7] T. Mak,et al. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. , 2000, Cancer research.
[8] C. Kahn,et al. Positive and Negative Regulation of Phosphoinositide 3-Kinase-Dependent Signaling Pathways by Three Different Gene Products of the p85α Regulatory Subunit , 2000, Molecular and Cellular Biology.
[9] S. O’Rahilly,et al. Natural variants of human p85α phosphoinositide 3-kinase in severe insulin resistance: a novel variant with impaired insulin-stimulated lipid kinase activity , 2000, Diabetologia.
[10] Kohjiro Ueki,et al. Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] I. Campbell,et al. The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. , 2001, Cancer research.
[12] John F. Timms,et al. Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer , 2001 .
[13] K. Okkenhaug,et al. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. , 2001, Annual review of cell and developmental biology.
[14] Kohjiro Ueki,et al. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. , 2002, The Journal of clinical investigation.
[15] W. Fiedler,et al. Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO) , 2002, Leukemia.
[16] Kohjiro Ueki,et al. Molecular Balance between the Regulatory and Catalytic Subunits of Phosphoinositide 3-Kinase Regulates Cell Signaling and Survival , 2002, Molecular and Cellular Biology.
[17] J. Klein,et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. , 2003, The Journal of biological chemistry.
[18] M. D. Chamberlain,et al. The p85α Subunit of Phosphatidylinositol 3′-Kinase Binds to and Stimulates the GTPase Activity of Rab Proteins* , 2004, Journal of Biological Chemistry.
[19] J. Engelman,et al. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex , 2005, The Journal of cell biology.
[20] R. Chagpar,et al. A-Raf associates with and regulates platelet-derived growth factor receptor signalling. , 2005, Cellular signalling.
[21] M. Loda,et al. Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Engelman,et al. Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice , 2005, Molecular and Cellular Biology.
[23] V. Sossi,et al. Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity , 2006, Diabetologia.
[24] D. F. Barber,et al. PTEN Regulation, a Novel Function for the p85 Subunit of Phosphoinositide 3-Kinase , 2006, Science's STKE.
[25] Yoko Takahashi,et al. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling , 2006, The EMBO journal.
[26] C. Kahn,et al. Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN , 2006, Proceedings of the National Academy of Sciences.
[27] Y. Samuels,et al. Oncogenic PI3K and its role in cancer , 2006, Current opinion in oncology.
[28] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[29] Pier Paolo Pandolfi,et al. The PTEN–PI3K pathway: of feedbacks and cross-talks , 2008, Oncogene.
[30] J. Xiang,et al. Disrupted RabGAP Function of the p85 Subunit of Phosphatidylinositol 3-Kinase Results in Cell Transformation* , 2008, Journal of Biological Chemistry.
[31] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[32] L. Cantley,et al. PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.
[33] B. Peters,et al. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. , 2009, Cancer cell.
[34] F. Vazquez,et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN , 2009, Proceedings of the National Academy of Sciences.
[35] W. Sellers,et al. p85 Associates with Unphosphorylated PTEN and the PTEN-Associated Complex , 2009, Molecular and Cellular Biology.